You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 302 No. 16, October 28, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Cervical Cancer
 •Women's Health
 •Women's Health, Other
 •Diagnosis
 •Prognosis/ Outcomes
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Screening and Prevention Methods for Cervical Cancer

Mark Schiffman, MD, MPH; Diane Solomon, MD

JAMA. 2009;302(16):1809-1810.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Automated, liquid-based cytology has virtually replaced conventional Papanicolaou (Pap) smears in the United States. However, in this issue of JAMA, Siebers et al1 demonstrate in a large randomized clinical trial that the most common liquid-based cytology method is no better for detection of cervical precancer than well-performed Pap smears. This trial confirms a recent meta-analysis that also showed no incremental improvement in accuracy using liquid-based cytology.2

Siebers et al randomized 246 Dutch family practices including almost 90 000 women to either liquid-based cytology or conventional Pap smears. Two laboratories participated; 1 laboratory already had 1 year of previous experience interpreting liquid-based cytology. The precancer outcomes (ie, detection of cervical cancer precursors) were defined by histology or repeat cytology, tracked by registry linkage over an 18-month period, and carefully confirmed by reviewers masked to the screening method.

The 2 cytology methods provided similar risk . . . [Full Text of this Article]

Author Affiliations: Division of Cancer Epidemiology and Genetics (Dr Schiffman), and Division of Cancer Prevention (Dr Solomon), National Cancer Institute, National Institutes of Health, Bethesda, Maryland.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Comparison of Liquid-Based Cytology With Conventional Cytology for Detection of Cervical Cancer Precursors: A Randomized Controlled Trial
Albertus G. Siebers, Paul J. J. M. Klinkhamer, Johanna M. M. Grefte, Leon F. A. G. Massuger, Judith E. M. Vedder, Angelique Beijers-Broos, Johan Bulten, and Marc Arbyn
JAMA. 2009;302(16):1757-1764.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

For Detecting CIN, Cytology Method Might Not Matter
JWatch Women's Health 2009;2009:5-5.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.